Drug Shortage Report for ABRILADA
| Report ID | 173490 |
| Drug Identification Number | 02511053 |
| Brand name | ABRILADA |
| Common or Proper name | ABRILADA |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ADALIMUMAB |
| Strength(s) | 40MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Packaging size | 40MG / 0.8ML |
| ATC code | L04AB |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-12-09 |
| Actual start date | |
| Estimated end date | 2023-01-20 |
| Actual end date | 2022-12-07 |
| Shortage status | Avoided shortage |
| Updated date | 2022-12-08 |
| Company comments | Abrilada 40mg/0.8mL SSOL 1x2 Pre Filled Syringe currently on Preventive Allocation Abrilada 40mg/0.8mL SSOL 1x2 Pre Filled Pen presentation is available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2022-12-08 | French | Compare |
| v4 | 2022-12-08 | English | Compare |
| v3 | 2022-11-29 | English | Compare |
| v2 | 2022-11-03 | French | Compare |
| v1 | 2022-11-03 | English | Compare |
Showing 1 to 5 of 5